Clinical pharmacology and clinical trials in Japan

Journal of Molecular Medicine

Volumn 74, Issue 8, 1996, Pages 479-486

  Ebihara, A ^a   Takahashi, K ^b   Ikemoto, F ^c   Yamamoto, K ^d  

^a Shin Oyama City Hospital   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

^c Development Research Laboratories   (Japan)

^d Osaka Prefecture University   (Japan)

Author keywords

Clinical pharmacology; Clinical trials; Drug development; Drug therapeutics; Informed consent

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; DRUG INDUSTRY; DRUG RESEARCH; EDUCATION PROGRAM; GOOD CLINICAL PRACTICE; INFORMED CONSENT; MEDICAL EDUCATION;

EID: 0029784862     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00217525     Document Type: Article

References (21)

1. Nierenberg DW, Melmon KL (1992) Introduction to clinical pharmacology. In: Melmon KL, Morrelli HF, Hoffman BB, Nierenberg DW (ed.) Clinical pharmacology basic principles in therapeutics. McGraw-Hill, New York, pp 1-51
2. Nakamura K, Nakano S (1994) Education on clinical study: undergraduate education: double-blind test on drug effects. Jpn Pharmacol Ther 22:2033-2041
3. Kawai S (1994) Education on clinical study: to improve the quality of physicians participating in clinical studies. Jpn Pharmacol Ther 22:1659-1664
4. Fukushima M (1995) Clinical trials in Japan. Nature Medicine 1:12-13
5. Temple R, Bilstad J, O'Neille R, Bass R, Shimizu N, Sakuma A, Satoh Y, Kurihara M, Naitoh C, Chihiro H (1994) Global judgment in the clinical trial: especially, on the problem of clinical utility. Clin Eval 22:19-42
6. Honma M, Akizuki M, Alexadre JM Michard M, Esber EC, Bilstad J, Darrow WR, Naitoh C, Kurokawa T (1994) The harmonization of clinical trials among Japan. Europe, and USA for possible improvement of Japan's clinical trial. J Clin Ther Med 10:1237-1250
7. Sunahara M (1988) Internationalization of clinical trials. Jpn J Clin Pharmacol Ther 19:465-468
8. Shimizu N (1988) Comparison of clinical trials in Japan and the US. Jpn J Clin Pharmacol Ther 19:481-484
9. Kurokawa T (1990) A brief introduction for good clinical practice for trials on drugs. Clin Eval 18:491-195
10. Tanaka T (1980) Planning of clinical trials in later phases. In: Ebihara A (ed) Manual for the development of drugs for adult diseases. Fuji Techno-system, pp 255-263
11. Kitabatake A, Nomura A (1994) How to promote and explain the significance of clinical trials to the patients. J Clin Ther Med 10:1009-1013
12. Takahashi K, Watanabe M, Nomura A, Kitabatake A (1995) Problems and perspectives in clinical trials in Japan: comparison to those in US clinical trials. Jpn Pharmacol Ther 23: 3165-3175
13. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N End J Med 325:293-301
14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462
15. The Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet 344:1383-1389
16. Nakamura K (1994) International comparison of conception on placebo use in clinical trials. J Clin Ther Med 9:1273-1279
17. Nakashima M (1995) Proposal for qualitative Improvement on clinical trial: proposal by a controller. Jpn Pharmacol Ther 23:777-783
18. Kageyama S (1994) Reasons for the difficulty in the use of placebo in clinical trials. J Clin Ther Med 9:1009-1013
19. Kageyama S (1994) Significance of clinical trials. II. Promotion of social understanding. Jpn Pharmacol Ther 22: 1129-1134
20. Nakamura K (1994) Comparison of conception on placebo use in clinical trials among USA, EU and Japan. J Clin Ther Med 9:1273-1279
21. Nomura A, Takahashi K, Kitabatake A (1995) The present opinion of patients and doctors toward informed consent for clinical trials following the implementation of Good Clinical Practice. Jpn J Pharmacol Ther 26:897-902